Glenmark recalls 6,528 bottles of BP drug in US
April 20, 2024
Source: drugdu
116
Glenmark Pharmaceuticals is recalling 6,528 bottles of Diltiazem Hydrochloride extended-release capsules, a medication used to treat high blood pressure in the American market due to failed dissolution specifications, informed USFDA in its latest Enforcement Report.
The affected lot has been produced in India and is being recalled for “failed dissolution specifications”, the USFDA said.
“Out of Specification (OOS) was reported in a test of dissolution at the 12th month time point in long-term stability study,” it noted.
Glenmark initiated Class II recall of the drug across the US on March 26 this year.
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
https://www.business-standard.com/companies/news/glenmark-pharma-recalls-6-528-bottles-of-blood-pressure-drug-in-us-124041400116_1.html
By editor
Copyright©2024 Ddu. All rights reserved.
Read more on
- As the industry is going down, more and more pharmaceutical companies are seeking to “exit”? November 22, 2024
- Regeneron’s midlife crisis November 22, 2024
- This “excellent hospital director” took the initiative to explain the problem November 22, 2024
- The director of the National Medical Insurance Bureau expressed his position to promote direct settlement of medical insurance November 22, 2024
- Over 5.7 billion! China’s dual antibody ADC goes global+1 November 21, 2024
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
